XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.21.2

Segment and Related Information | 9 Months Ended
--- | ---
Sep. 30, 2021
Segment Reporting [Abstract] |
Segment and Related Information | SEGMENT AND RELATED INFORMATIONThe Company’s business is aligned with how the chief operating decision maker reviews performance and makes decisions in managing the Company. The business units have been aggregated into two reportable segments: (i) diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology. Segment revenue and operating income (loss) were as follows during the periods presented:
(in millions) | Diagnostics |  | Other |  | Total
Three months ended September 30, 2021 |  |  |  |  |
Revenues | $ | 161.7 |  |  | $ | 5.6 |  |  | $ | 167.3 |
Depreciation and amortization | 13.1 |  |  | 1.1 |  |  | 14.2 |
Segment operating loss | (21.7) |  |  | (58.2) |  |  | (79.9) |
Three months ended September 30, 2020 |  |  |  |  |
Revenues | $ | 130.5 |  |  | $ | 14.7 |  |  | $ | 145.2 |
Depreciation and amortization | 16.7 |  |  | 1.0 |  |  | 17.7 |
Segment operating loss | (0.3) |  |  | (39.3) |  |  | (39.6) |
Nine months ended September 30, 2021 |  |  |  |  |
Revenues | $ | 496.6 |  |  | $ | 33.2 |  |  | $ | 529.8 |
Depreciation and amortization | 45.8 |  |  | 3.7 |  |  | 49.5 |
Segment operating income (loss) | 26.3 |  |  | (173.7) |  |  | (147.4) |
Nine months ended September 30, 2020 |  |  |  |  |
Revenues | $ | 362.0 |  |  | $ | 40.4 |  |  | $ | 402.4 |
Depreciation and amortization | 50.2 |  |  | 3.1 |  |  | 53.3 |
Segment operating loss | (127.7) |  |  | (113.9) |  |  | (241.6) |
| Three months ended September 30, |  | Nine months ended September 30,
(in millions) | 2021 |  |  | 2020 |  | 2021 |  |  | 2020
Total operating loss for reportable segments | $ | (79.9) |  |  |  | $ | (39.6) |  |  | $ | (147.4) |  |  |  | $ | (241.6) |
Unallocated amounts: |  |  |  |  |  |  |  |  |
Interest income | 0.2 |  |  |  | 0.4 |  |  | 0.6 |  |  |  | 1.7 |
Interest expense | (1.1) |  |  |  | (2.9) |  |  | (6.1) |  |  |  | (8.3) |
Other | 120.6 |  |  |  | (1.6) |  |  | 139.3 |  |  |  | 14.9 |
Income (loss) from operations before income taxes | 39.8 |  |  |  | (43.7) |  |  | (13.6) |  |  |  | (233.3) |
Income tax expense (benefit) | 15.2 |  |  |  | (28.5) |  |  | 6.0 |  |  |  | (47.4) |
Net income (loss) | 24.6 |  |  |  | (15.2) |  |  | (19.6) |  |  |  | (185.9) |
Net loss attributable to non-controlling interest | — |  |  |  | — |  |  | — |  |  |  | (0.1) |
Net income (loss) attributable to Myriad Genetics, Inc. stockholders | $ | 24.6 |  |  |  | $ | (15.2) |  |  | $ | (19.6) |  |  |  | $ | (185.8) |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration